

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | fat-soluble vitamin biosynthetic process (GO:0042362) | 8.70056172 |
| 2 | sulfation (GO:0051923) | 7.01515415 |
| 3 | regulation of glomerulus development (GO:0090192) | 6.47311733 |
| 4 | vitamin transmembrane transport (GO:0035461) | 6.47280040 |
| 5 | cellular response to ATP (GO:0071318) | 6.25292144 |
| 6 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 6.18843921 |
| 7 | response to pheromone (GO:0019236) | 5.84837519 |
| 8 | regulation of cell proliferation involved in kidney development (GO:1901722) | 5.76642008 |
| 9 | regulation of phospholipid biosynthetic process (GO:0071071) | 5.30532060 |
| 10 | vascular endothelial growth factor signaling pathway (GO:0038084) | 5.28503546 |
| 11 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 5.22553093 |
| 12 | protein targeting to Golgi (GO:0000042) | 4.98240335 |
| 13 | low-density lipoprotein particle clearance (GO:0034383) | 4.94859105 |
| 14 | regulation of sequestering of triglyceride (GO:0010889) | 4.90275095 |
| 15 | negative regulation of systemic arterial blood pressure (GO:0003085) | 4.78911657 |
| 16 | monoubiquitinated protein deubiquitination (GO:0035520) | 4.78606804 |
| 17 | water-soluble vitamin biosynthetic process (GO:0042364) | 4.66202150 |
| 18 | indole-containing compound catabolic process (GO:0042436) | 4.57709254 |
| 19 | indolalkylamine catabolic process (GO:0046218) | 4.57709254 |
| 20 | tryptophan catabolic process (GO:0006569) | 4.57709254 |
| 21 | positive regulation of metanephros development (GO:0072216) | 4.55427494 |
| 22 | establishment of protein localization to Golgi (GO:0072600) | 4.52482539 |
| 23 | regulation of DNA endoreduplication (GO:0032875) | 4.50849473 |
| 24 | cell proliferation in forebrain (GO:0021846) | 4.50254415 |
| 25 | behavioral response to nicotine (GO:0035095) | 4.49077680 |
| 26 | regulation of establishment or maintenance of cell polarity (GO:0032878) | 4.43483337 |
| 27 | nuclear pore complex assembly (GO:0051292) | 4.42748481 |
| 28 | positive regulation of cAMP-mediated signaling (GO:0043950) | 4.42138616 |
| 29 | retrograde transport, vesicle recycling within Golgi (GO:0000301) | 4.40355619 |
| 30 | kynurenine metabolic process (GO:0070189) | 4.28228849 |
| 31 | negative regulation of platelet activation (GO:0010544) | 4.25916935 |
| 32 | epithelial to mesenchymal transition involved in endocardial cushion formation (GO:0003198) | 4.21106119 |
| 33 | dorsal/ventral axis specification (GO:0009950) | 4.19935274 |
| 34 | positive regulation of protein autophosphorylation (GO:0031954) | 4.16442385 |
| 35 | pharyngeal system development (GO:0060037) | 4.06377123 |
| 36 | heart trabecula formation (GO:0060347) | 4.03653939 |
| 37 | negative regulation of axon extension involved in axon guidance (GO:0048843) | 3.89501177 |
| 38 | iron ion import (GO:0097286) | 3.86773920 |
| 39 | otic vesicle formation (GO:0030916) | 3.86356256 |
| 40 | flavonoid metabolic process (GO:0009812) | 3.86222408 |
| 41 | 3-phosphoadenosine 5-phosphosulfate metabolic process (GO:0050427) | 3.83420024 |
| 42 | purine ribonucleoside bisphosphate metabolic process (GO:0034035) | 3.83420024 |
| 43 | negative regulation of endothelial cell apoptotic process (GO:2000352) | 3.81031540 |
| 44 | tryptophan metabolic process (GO:0006568) | 3.77839424 |
| 45 | negative regulation of cardiac muscle tissue development (GO:0055026) | 3.77167231 |
| 46 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.73112899 |
| 47 | positive regulation of actin cytoskeleton reorganization (GO:2000251) | 3.71343635 |
| 48 | nuclear pore organization (GO:0006999) | 3.68868242 |
| 49 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.65871058 |
| 50 | regulation of gene silencing by miRNA (GO:0060964) | 3.65871058 |
| 51 | regulation of gene silencing by RNA (GO:0060966) | 3.65871058 |
| 52 | positive regulation of focal adhesion assembly (GO:0051894) | 3.60649078 |
| 53 | positive regulation of cell junction assembly (GO:1901890) | 3.60649078 |
| 54 | indolalkylamine metabolic process (GO:0006586) | 3.59087532 |
| 55 | positive regulation of glomerulus development (GO:0090193) | 3.58822921 |
| 56 | opsonization (GO:0008228) | 3.57136629 |
| 57 | tooth mineralization (GO:0034505) | 3.56639567 |
| 58 | positive regulation of adherens junction organization (GO:1903393) | 3.51056544 |
| 59 | N-acetylglucosamine metabolic process (GO:0006044) | 3.49806740 |
| 60 | sprouting angiogenesis (GO:0002040) | 3.44156720 |
| 61 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 3.43975495 |
| 62 | regulation of metanephros development (GO:0072215) | 3.40732401 |
| 63 | quaternary ammonium group transport (GO:0015697) | 3.37545327 |
| 64 | negative chemotaxis (GO:0050919) | 3.35737592 |
| 65 | lymphangiogenesis (GO:0001946) | 3.34679334 |
| 66 | sperm motility (GO:0030317) | 3.34231287 |
| 67 | negative regulation of hormone biosynthetic process (GO:0032353) | 3.31958357 |
| 68 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.29951405 |
| 69 | regulation of hippo signaling (GO:0035330) | 3.29258309 |
| 70 | gamma-aminobutyric acid transport (GO:0015812) | 3.24580567 |
| 71 | plasma membrane repair (GO:0001778) | 3.22223853 |
| 72 | negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518) | 3.19769208 |
| 73 | estrogen metabolic process (GO:0008210) | 3.17110246 |
| 74 | negative regulation of axon guidance (GO:1902668) | 3.16975271 |
| 75 | negative regulation of mast cell activation (GO:0033004) | 3.16580708 |
| 76 | N-terminal protein amino acid acetylation (GO:0006474) | 3.13610279 |
| 77 | trabecula formation (GO:0060343) | 3.11466529 |
| 78 | limb bud formation (GO:0060174) | 3.11181939 |
| 79 | negative regulation of response to food (GO:0032096) | 3.11036476 |
| 80 | negative regulation of appetite (GO:0032099) | 3.11036476 |
| 81 | histone H3-K9 demethylation (GO:0033169) | 3.10425852 |
| 82 | pore complex assembly (GO:0046931) | 3.10407038 |
| 83 | regulation of protein autophosphorylation (GO:0031952) | 3.10345185 |
| 84 | embryonic hindlimb morphogenesis (GO:0035116) | 3.10311098 |
| 85 | ear development (GO:0043583) | 3.09816602 |
| 86 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.08966135 |
| 87 | import into cell (GO:0098657) | 3.08005065 |
| 88 | macroautophagy (GO:0016236) | 3.07285798 |
| 89 | keratan sulfate biosynthetic process (GO:0018146) | 3.06322703 |
| 90 | negative regulation of transcription regulatory region DNA binding (GO:2000678) | 3.06167083 |
| 91 | regulation of endothelial cell apoptotic process (GO:2000351) | 3.01983782 |
| 92 | regulation of odontogenesis of dentin-containing tooth (GO:0042487) | 3.01596819 |
| 93 | vitamin biosynthetic process (GO:0009110) | 3.00887912 |
| 94 | regulation of mesoderm development (GO:2000380) | 2.99900312 |
| 95 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.98784923 |
| 96 | endothelial cell proliferation (GO:0001935) | 2.97119236 |
| 97 | DNA deamination (GO:0045006) | 2.96920738 |
| 98 | negative regulation of inclusion body assembly (GO:0090084) | 2.96186613 |
| 99 | regulation of vascular permeability (GO:0043114) | 2.94568407 |
| 100 | artery development (GO:0060840) | 2.94546741 |
| 101 | regulation of RNA export from nucleus (GO:0046831) | 2.94408723 |
| 102 | cellular anion homeostasis (GO:0030002) | 2.94369798 |
| 103 | negative regulation by host of viral transcription (GO:0043922) | 2.93627540 |
| 104 | fusion of sperm to egg plasma membrane (GO:0007342) | 2.92622378 |
| 105 | negative regulation of fibrinolysis (GO:0051918) | 2.92324285 |
| 106 | regulation of Wnt signaling pathway involved in heart development (GO:0003307) | 2.90633894 |
| 107 | negative regulation of protein autophosphorylation (GO:0031953) | 2.90439803 |
| 108 | indole-containing compound metabolic process (GO:0042430) | 2.90320594 |
| 109 | regulation of podosome assembly (GO:0071801) | 2.89456340 |
| 110 | positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552) | 2.88084041 |
| 111 | smooth muscle tissue development (GO:0048745) | 2.82746448 |
| 112 | regulation of protein polyubiquitination (GO:1902914) | 2.82265547 |
| 113 | negative regulation of vascular permeability (GO:0043116) | 2.81027572 |
| 114 | protein polyglutamylation (GO:0018095) | 2.80937114 |
| 115 | modified amino acid transport (GO:0072337) | 2.79739543 |
| 116 | positive regulation of p38MAPK cascade (GO:1900745) | 2.78160638 |
| 117 | negative regulation of hormone metabolic process (GO:0032351) | 2.76748263 |
| 118 | positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949) | 2.75769221 |
| 119 | protein localization to endosome (GO:0036010) | 2.74152378 |
| 120 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.73686993 |
| 121 | lung morphogenesis (GO:0060425) | 2.73183075 |
| 122 | musculoskeletal movement (GO:0050881) | 2.72880701 |
| 123 | multicellular organismal movement (GO:0050879) | 2.72880701 |
| 124 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 2.72397899 |
| 125 | positive regulation of fatty acid oxidation (GO:0046321) | 2.72326075 |
| 126 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.72035569 |
| 127 | response to ATP (GO:0033198) | 2.71283360 |
| 128 | cellular response to exogenous dsRNA (GO:0071360) | 2.71233398 |
| 129 | definitive hemopoiesis (GO:0060216) | 2.70942755 |
| 130 | amine catabolic process (GO:0009310) | 2.70343431 |
| 131 | cellular biogenic amine catabolic process (GO:0042402) | 2.70343431 |
| 132 | regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640) | 2.70152768 |
| 133 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.69457168 |
| 134 | regulation of germinal center formation (GO:0002634) | 2.68073047 |
| 135 | S-adenosylmethionine metabolic process (GO:0046500) | 2.67192054 |
| 136 | organ induction (GO:0001759) | 2.66246054 |
| 137 | positive regulation of lipid kinase activity (GO:0090218) | 2.63491973 |
| 138 | hippo signaling (GO:0035329) | 2.63338063 |
| 139 | regulation of collateral sprouting (GO:0048670) | 2.62592460 |
| 140 | keratan sulfate metabolic process (GO:0042339) | 2.62438486 |
| 141 | angiogenesis involved in wound healing (GO:0060055) | 2.60817025 |
| 142 | positive regulation of lipid storage (GO:0010884) | 2.60128440 |
| 143 | establishment of endothelial barrier (GO:0061028) | 2.59951491 |
| 144 | negative regulation of blood pressure (GO:0045776) | 2.59153962 |
| 145 | head development (GO:0060322) | 2.58999273 |
| 146 | positive regulation of glycolytic process (GO:0045821) | 2.58650312 |
| 147 | fatty acid transmembrane transport (GO:1902001) | 2.58220028 |
| 148 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 2.56402796 |
| 149 | somite development (GO:0061053) | 2.56307668 |
| 150 | mitotic sister chromatid cohesion (GO:0007064) | 2.55845915 |
| 151 | mesonephros development (GO:0001823) | 2.54456480 |
| 152 | positive regulation of hormone biosynthetic process (GO:0046886) | 2.53980040 |
| 153 | acrosome assembly (GO:0001675) | 2.53608570 |
| 154 | carnitine shuttle (GO:0006853) | 2.52308341 |
| 155 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.50925710 |
| 156 | reflex (GO:0060004) | 2.50798183 |
| 157 | carnitine transmembrane transport (GO:1902603) | 2.49322794 |
| 158 | regulation of cholesterol homeostasis (GO:2000188) | 2.48420847 |
| 159 | lung vasculature development (GO:0060426) | 2.48128010 |
| 160 | secondary heart field specification (GO:0003139) | 2.46790958 |
| 161 | heart field specification (GO:0003128) | 2.46790958 |
| 162 | regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358) | 2.46667055 |
| 163 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.46371430 |
| 164 | regulation of cholesterol storage (GO:0010885) | 2.46100984 |
| 165 | prostate gland growth (GO:0060736) | 2.46073155 |
| 166 | hindlimb morphogenesis (GO:0035137) | 2.44494078 |
| 167 | serotonin metabolic process (GO:0042428) | 2.43409648 |
| 168 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.43012775 |
| 169 | branching involved in salivary gland morphogenesis (GO:0060445) | 2.41794835 |
| 170 | peristalsis (GO:0030432) | 2.41493058 |
| 171 | positive regulation of lipid catabolic process (GO:0050996) | 2.41028579 |
| 172 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.40924901 |
| 173 | regulation of fatty acid beta-oxidation (GO:0031998) | 2.40327411 |
| 174 | amino-acid betaine transport (GO:0015838) | 2.40092529 |
| 175 | carnitine transport (GO:0015879) | 2.40092529 |
| 176 | negative regulation of receptor-mediated endocytosis (GO:0048261) | 2.37224526 |
| 177 | regulation of phosphatidylinositol 3-kinase activity (GO:0043551) | 2.35203949 |
| 178 | wound healing, spreading of epidermal cells (GO:0035313) | 2.33193437 |
| 179 | patterning of blood vessels (GO:0001569) | 2.31365842 |
| 180 | synaptonemal complex assembly (GO:0007130) | 2.30406961 |
| 181 | female genitalia development (GO:0030540) | 2.29629971 |
| 182 | protein localization to Golgi apparatus (GO:0034067) | 2.28997203 |
| 183 | piRNA metabolic process (GO:0034587) | 2.28897283 |
| 184 | peptidyl-threonine dephosphorylation (GO:0035970) | 2.28059215 |
| 185 | lung epithelium development (GO:0060428) | 2.27529078 |
| 186 | diaphragm development (GO:0060539) | 2.26833748 |
| 187 | regulation of protein import into nucleus, translocation (GO:0033158) | 2.26514877 |
| 188 | polyol transport (GO:0015791) | 2.24126423 |
| 189 | regulation of transforming growth factor beta2 production (GO:0032909) | 2.24072050 |
| 190 | negative regulation of lipid storage (GO:0010888) | 2.23752066 |
| 191 | regulation of nucleobase-containing compound transport (GO:0032239) | 2.22656222 |
| 192 | eyelid development in camera-type eye (GO:0061029) | 2.22561713 |
| 193 | cell wall macromolecule catabolic process (GO:0016998) | 2.21917727 |
| 194 | cell wall macromolecule metabolic process (GO:0044036) | 2.21917727 |
| 195 | anterior/posterior axis specification, embryo (GO:0008595) | 2.20232332 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 4.05009391 |
| 2 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 4.00935893 |
| 3 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 3.30981399 |
| 4 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.73513176 |
| 5 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 2.62446874 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.60778955 |
| 7 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 2.45444621 |
| 8 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.39278145 |
| 9 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.34177799 |
| 10 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.25268021 |
| 11 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.22673040 |
| 12 | EWS_26573619_Chip-Seq_HEK293_Human | 2.09403305 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.08360924 |
| 14 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.03591631 |
| 15 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 2.01169817 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.97322037 |
| 17 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.91651722 |
| 18 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.91633148 |
| 19 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.91388310 |
| 20 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.89834813 |
| 21 | P300_19829295_ChIP-Seq_ESCs_Human | 1.89035071 |
| 22 | FUS_26573619_Chip-Seq_HEK293_Human | 1.88519313 |
| 23 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.83336397 |
| 24 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.81727256 |
| 25 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.79249420 |
| 26 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.77410470 |
| 27 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.77325582 |
| 28 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.76828091 |
| 29 | * AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.75311507 |
| 30 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.72199401 |
| 31 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.71670520 |
| 32 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.70676758 |
| 33 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.69420742 |
| 34 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.68942103 |
| 35 | TP53_16413492_ChIP-PET_HCT116_Human | 1.66495889 |
| 36 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.65212547 |
| 37 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.64157416 |
| 38 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.63520534 |
| 39 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.62005780 |
| 40 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.60578111 |
| 41 | VDR_22108803_ChIP-Seq_LS180_Human | 1.59075297 |
| 42 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.58977774 |
| 43 | CJUN_26792858_Chip-Seq_BT549_Human | 1.58867323 |
| 44 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.58755508 |
| 45 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.57980290 |
| 46 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.57980290 |
| 47 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.56021146 |
| 48 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.54497868 |
| 49 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.52235275 |
| 50 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.48111414 |
| 51 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.48023307 |
| 52 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.45668680 |
| 53 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.44803230 |
| 54 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.44628494 |
| 55 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.44042200 |
| 56 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.43937184 |
| 57 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.43315238 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.43045448 |
| 59 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.39175292 |
| 60 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38757069 |
| 61 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.38715771 |
| 62 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.38715771 |
| 63 | POU5F1_16153702_ChIP-ChIP_HESCs_Human | 1.38527202 |
| 64 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.37997770 |
| 65 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.36854580 |
| 66 | * ELK4_26923725_Chip-Seq_MESODERM_Mouse | 1.36602057 |
| 67 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.36106781 |
| 68 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 1.36074940 |
| 69 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.35777423 |
| 70 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34103853 |
| 71 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.34019000 |
| 72 | * TCF3_18692474_ChIP-Seq_MESCs_Mouse | 1.33771552 |
| 73 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.32866862 |
| 74 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.31480150 |
| 75 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.30951033 |
| 76 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.30832291 |
| 77 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.30485934 |
| 78 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.30274856 |
| 79 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.29490611 |
| 80 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.28835025 |
| 81 | ZIC3_20872845_ChIP-ChIP_MESCs_Mouse | 1.27782104 |
| 82 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 1.27414260 |
| 83 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.26758217 |
| 84 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.25787721 |
| 85 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.25787721 |
| 86 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.25297786 |
| 87 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25054985 |
| 88 | STAT3_24763339_ChIP-Seq_IMN-ESCs_Mouse | 1.24179015 |
| 89 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.23149680 |
| 90 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.23149166 |
| 91 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.22564928 |
| 92 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.22190640 |
| 93 | * TP53_18474530_ChIP-ChIP_U2OS_Human | 1.20851995 |
| 94 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.20669902 |
| 95 | MYC_20876797_ChIP-ChIP_MEDULLOBLASTOMA_Human | 1.20336597 |
| 96 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.20236207 |
| 97 | * CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.19887400 |
| 98 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.19849185 |
| 99 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.19058018 |
| 100 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18555007 |
| 101 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.16834611 |
| 102 | * SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.16412312 |
| 103 | AR_25329375_ChIP-Seq_VCAP_Human | 1.16408884 |
| 104 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16337874 |
| 105 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.15998949 |
| 106 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.15551478 |
| 107 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.15534311 |
| 108 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.13565030 |
| 109 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.12748002 |
| 110 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.12623582 |
| 111 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.12295893 |
| 112 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.11531193 |
| 113 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.11527783 |
| 114 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.11523716 |
| 115 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 1.11250870 |
| 116 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.10504725 |
| 117 | * TCF3_18347094_ChIP-ChIP_MESCs_Mouse | 1.09844978 |
| 118 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.09771398 |
| 119 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.09628702 |
| 120 | FLI1_21867929_ChIP-Seq_TH2_Mouse | 1.09503495 |
| 121 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 1.09403516 |
| 122 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.09254761 |
| 123 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 1.08695927 |
| 124 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.08442018 |
| 125 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.08342949 |
| 126 | * KDM2B_26808549_Chip-Seq_REH_Human | 1.08062656 |
| 127 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.07580616 |
| 128 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.07474799 |
| 129 | * SOX2_18358816_ChIP-ChIP_MESCs_Mouse | 1.07218178 |
| 130 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.07036238 |
| 131 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 1.06615719 |
| 132 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.06198269 |
| 133 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.05836842 |
| 134 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.05814937 |
| 135 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.05262553 |
| 136 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.05209259 |
| 137 | EWS-ERG_20517297_ChIP-Seq_CADO-ES1_Human | 1.04496630 |
| 138 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 1.04296356 |
| 139 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.04101318 |
| 140 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04050168 |
| 141 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.03968872 |
| 142 | NANOG_19829295_ChIP-Seq_ESCs_Human | 1.02775883 |
| 143 | SOX2_19829295_ChIP-Seq_ESCs_Human | 1.02775883 |
| 144 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.02427753 |
| 145 | STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.02262590 |
| 146 | * NANOG_18347094_ChIP-ChIP_MESCs_Mouse | 1.02195816 |
| 147 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.01874959 |
| 148 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.99815866 |
| 149 | RXR_22108803_ChIP-Seq_LS180_Human | 0.99167054 |
| 150 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.98627897 |
| 151 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 0.98309688 |
| 152 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 0.98309688 |
| 153 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 0.98309688 |
| 154 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.98046513 |
| 155 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.97444658 |
| 156 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.96818383 |
| 157 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.96279322 |
| 158 | STAT3_23295773_ChIP-Seq_U87_Human | 0.95055854 |
| 159 | * PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.92999037 |
| 160 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.90304700 |
| 161 | TBX3_20139965_ChIP-Seq_MESCs_Mouse | 0.90290629 |
| 162 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.90162259 |
| 163 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.89879107 |
| 164 | TBX3_20139965_ChIP-Seq_ESCs_Mouse | 0.89502867 |
| 165 | FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 0.89184023 |
| 166 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.88778050 |
| 167 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.88115430 |
| 168 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.87117491 |
| 169 | TBL1_22424771_ChIP-Seq_293T_Human | 0.86824976 |
| 170 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.85864305 |
| 171 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.84979146 |
| 172 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.84874858 |
| 173 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.84792336 |
| 174 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.83316742 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0005670_abnormal_white_adipose | 5.16421541 |
| 2 | MP0003195_calcinosis | 5.07006724 |
| 3 | MP0004134_abnormal_chest_morphology | 3.80655865 |
| 4 | MP0002138_abnormal_hepatobiliary_system | 3.62273741 |
| 5 | MP0005410_abnormal_fertilization | 3.22790490 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.12525665 |
| 7 | MP0005666_abnormal_adipose_tissue | 3.08795814 |
| 8 | MP0008438_abnormal_cutaneous_collagen | 3.01434045 |
| 9 | MP0004185_abnormal_adipocyte_glucose | 2.99137918 |
| 10 | MP0006138_congestive_heart_failure | 2.87766381 |
| 11 | MP0002160_abnormal_reproductive_system | 2.72170407 |
| 12 | MP0003646_muscle_fatigue | 2.59820336 |
| 13 | MP0003828_pulmonary_edema | 2.52548531 |
| 14 | MP0006292_abnormal_olfactory_placode | 2.47710764 |
| 15 | MP0005646_abnormal_pituitary_gland | 2.43567833 |
| 16 | MP0005275_abnormal_skin_tensile | 2.38983182 |
| 17 | MP0003950_abnormal_plasma_membrane | 2.38348433 |
| 18 | MP0005076_abnormal_cell_differentiation | 2.38073387 |
| 19 | MP0004145_abnormal_muscle_electrophysio | 2.35988631 |
| 20 | MP0009250_abnormal_appendicular_skeleto | 2.29014938 |
| 21 | MP0002254_reproductive_system_inflammat | 2.20623955 |
| 22 | MP0002876_abnormal_thyroid_physiology | 2.15606754 |
| 23 | MP0005375_adipose_tissue_phenotype | 2.15056876 |
| 24 | MP0002796_impaired_skin_barrier | 2.14747484 |
| 25 | MP0009278_abnormal_bone_marrow | 2.13016890 |
| 26 | MP0000049_abnormal_middle_ear | 2.12985334 |
| 27 | MP0003091_abnormal_cell_migration | 2.11463337 |
| 28 | MP0001485_abnormal_pinna_reflex | 2.11427371 |
| 29 | MP0004130_abnormal_muscle_cell | 2.09426716 |
| 30 | MP0001542_abnormal_bone_strength | 2.03998779 |
| 31 | MP0002108_abnormal_muscle_morphology | 2.03668909 |
| 32 | MP0005389_reproductive_system_phenotype | 2.02918801 |
| 33 | MP0009780_abnormal_chondrocyte_physiolo | 1.94684882 |
| 34 | MP0002877_abnormal_melanocyte_morpholog | 1.92930131 |
| 35 | MP0005167_abnormal_blood-brain_barrier | 1.87865362 |
| 36 | MP0000631_abnormal_neuroendocrine_gland | 1.87585544 |
| 37 | MP0005623_abnormal_meninges_morphology | 1.86645214 |
| 38 | MP0008872_abnormal_physiological_respon | 1.83478705 |
| 39 | MP0010234_abnormal_vibrissa_follicle | 1.80655639 |
| 40 | MP0003724_increased_susceptibility_to | 1.79951953 |
| 41 | MP0004272_abnormal_basement_membrane | 1.78070836 |
| 42 | MP0002139_abnormal_hepatobiliary_system | 1.74866972 |
| 43 | MP0010352_gastrointestinal_tract_polyps | 1.72756075 |
| 44 | MP0004885_abnormal_endolymph | 1.71142562 |
| 45 | MP0001853_heart_inflammation | 1.68649473 |
| 46 | MP0002837_dystrophic_cardiac_calcinosis | 1.68598785 |
| 47 | MP0009053_abnormal_anal_canal | 1.68305952 |
| 48 | MP0002295_abnormal_pulmonary_circulatio | 1.67842599 |
| 49 | MP0000013_abnormal_adipose_tissue | 1.66937457 |
| 50 | MP0005257_abnormal_intraocular_pressure | 1.58364666 |
| 51 | MP0000678_abnormal_parathyroid_gland | 1.56315463 |
| 52 | MP0003011_delayed_dark_adaptation | 1.55483935 |
| 53 | MP0004019_abnormal_vitamin_homeostasis | 1.54356483 |
| 54 | MP0002282_abnormal_trachea_morphology | 1.48751515 |
| 55 | MP0005084_abnormal_gallbladder_morpholo | 1.47877410 |
| 56 | MP0006072_abnormal_retinal_apoptosis | 1.45280630 |
| 57 | MP0010307_abnormal_tumor_latency | 1.43915902 |
| 58 | MP0001440_abnormal_grooming_behavior | 1.43823083 |
| 59 | MP0003638_abnormal_response/metabolism_ | 1.43548524 |
| 60 | MP0005365_abnormal_bile_salt | 1.41282851 |
| 61 | MP0009384_cardiac_valve_regurgitation | 1.41023152 |
| 62 | MP0003890_abnormal_embryonic-extraembry | 1.39765211 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 1.38732688 |
| 64 | MP0003566_abnormal_cell_adhesion | 1.38478267 |
| 65 | MP0000733_abnormal_muscle_development | 1.38422325 |
| 66 | MP0002148_abnormal_hypersensitivity_rea | 1.37872968 |
| 67 | MP0002277_abnormal_respiratory_mucosa | 1.36800063 |
| 68 | MP0010329_abnormal_lipoprotein_level | 1.32181216 |
| 69 | MP0009115_abnormal_fat_cell | 1.31758050 |
| 70 | MP0003567_abnormal_fetal_cardiomyocyte | 1.31386212 |
| 71 | MP0008961_abnormal_basal_metabolism | 1.31343986 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.31039530 |
| 73 | MP0002089_abnormal_postnatal_growth/wei | 1.30250692 |
| 74 | MP0003878_abnormal_ear_physiology | 1.29953273 |
| 75 | MP0005377_hearing/vestibular/ear_phenot | 1.29953273 |
| 76 | MP0003045_fibrosis | 1.26973373 |
| 77 | MP0002971_abnormal_brown_adipose | 1.26864434 |
| 78 | MP0000003_abnormal_adipose_tissue | 1.24172618 |
| 79 | MP0002163_abnormal_gland_morphology | 1.24006357 |
| 80 | MP0001299_abnormal_eye_distance/ | 1.23290691 |
| 81 | MP0009785_altered_susceptibility_to | 1.21547920 |
| 82 | MP0003937_abnormal_limbs/digits/tail_de | 1.21154383 |
| 83 | MP0001879_abnormal_lymphatic_vessel | 1.21099930 |
| 84 | MP0002060_abnormal_skin_morphology | 1.20970134 |
| 85 | MP0003806_abnormal_nucleotide_metabolis | 1.20604735 |
| 86 | MP0000569_abnormal_digit_pigmentation | 1.19815477 |
| 87 | MP0003941_abnormal_skin_development | 1.19697998 |
| 88 | MP0003943_abnormal_hepatobiliary_system | 1.14559421 |
| 89 | MP0005379_endocrine/exocrine_gland_phen | 1.14315752 |
| 90 | MP0000516_abnormal_urinary_system | 1.14171898 |
| 91 | MP0005367_renal/urinary_system_phenotyp | 1.14171898 |
| 92 | MP0010630_abnormal_cardiac_muscle | 1.12972291 |
| 93 | MP0004484_altered_response_of | 1.11746736 |
| 94 | MP0002735_abnormal_chemical_nociception | 1.10638952 |
| 95 | MP0005595_abnormal_vascular_smooth | 1.10015033 |
| 96 | MP0005448_abnormal_energy_balance | 1.09721139 |
| 97 | MP0004142_abnormal_muscle_tone | 1.09036538 |
| 98 | MP0002734_abnormal_mechanical_nocicepti | 1.08536042 |
| 99 | MP0003942_abnormal_urinary_system | 1.07425938 |
| 100 | MP0000230_abnormal_systemic_arterial | 1.07424792 |
| 101 | MP0004215_abnormal_myocardial_fiber | 1.06529517 |
| 102 | MP0009764_decreased_sensitivity_to | 1.06278682 |
| 103 | MP0000767_abnormal_smooth_muscle | 1.05863317 |
| 104 | MP0003448_altered_tumor_morphology | 1.05791633 |
| 105 | MP0010386_abnormal_urinary_bladder | 1.05730185 |
| 106 | MP0002925_abnormal_cardiovascular_devel | 1.05035352 |
| 107 | MP0004133_heterotaxia | 1.04609467 |
| 108 | MP0003300_gastrointestinal_ulcer | 1.04115890 |
| 109 | MP0001661_extended_life_span | 1.03043965 |
| 110 | MP0002697_abnormal_eye_size | 1.01244459 |
| 111 | MP0000163_abnormal_cartilage_morphology | 1.01166844 |
| 112 | MP0000383_abnormal_hair_follicle | 1.00962682 |
| 113 | MP0002009_preneoplasia | 1.00403242 |
| 114 | MP0009703_decreased_birth_body | 0.99739974 |
| 115 | MP0003698_abnormal_male_reproductive | 0.99696549 |
| 116 | MP0002086_abnormal_extraembryonic_tissu | 0.99352601 |
| 117 | MP0002118_abnormal_lipid_homeostasis | 0.98438544 |
| 118 | MP0001915_intracranial_hemorrhage | 0.97806152 |
| 119 | MP0001756_abnormal_urination | 0.96938438 |
| 120 | MP0005385_cardiovascular_system_phenoty | 0.96715868 |
| 121 | MP0001544_abnormal_cardiovascular_syste | 0.96715868 |
| 122 | MP0002102_abnormal_ear_morphology | 0.95963662 |
| 123 | MP0002928_abnormal_bile_duct | 0.95373960 |
| 124 | MP0005023_abnormal_wound_healing | 0.95215629 |
| 125 | MP0002733_abnormal_thermal_nociception | 0.94418849 |
| 126 | MP0005334_abnormal_fat_pad | 0.92338520 |
| 127 | MP0008877_abnormal_DNA_methylation | 0.91963194 |
| 128 | MP0001177_atelectasis | 0.91761456 |
| 129 | MP0000613_abnormal_salivary_gland | 0.91530776 |
| 130 | MP0010368_abnormal_lymphatic_system | 0.91372189 |
| 131 | MP0005360_urolithiasis | 0.88729899 |
| 132 | MP0009672_abnormal_birth_weight | 0.88709668 |
| 133 | MP0001919_abnormal_reproductive_system | 0.88638772 |
| 134 | MP0002088_abnormal_embryonic_growth/wei | 0.88059951 |
| 135 | MP0005248_abnormal_Harderian_gland | 0.86303168 |
| 136 | MP0002896_abnormal_bone_mineralization | 0.86191754 |
| 137 | MP0002168_other_aberrant_phenotype | 0.85903016 |
| 138 | MP0002006_tumorigenesis | 0.85716870 |
| 139 | MP0002272_abnormal_nervous_system | 0.85710997 |
| 140 | MP0001968_abnormal_touch/_nociception | 0.84689780 |
| 141 | MP0005380_embryogenesis_phenotype | 0.84393672 |
| 142 | MP0001672_abnormal_embryogenesis/_devel | 0.84393672 |
| 143 | MP0001784_abnormal_fluid_regulation | 0.81686642 |
| 144 | MP0008007_abnormal_cellular_replicative | 0.80767902 |
| 145 | MP0000428_abnormal_craniofacial_morphol | 0.79885817 |
| 146 | MP0000467_abnormal_esophagus_morphology | 0.79793798 |
| 147 | MP0001730_embryonic_growth_arrest | 0.79535027 |
| 148 | MP0003115_abnormal_respiratory_system | 0.79497648 |
| 149 | MP0000627_abnormal_mammary_gland | 0.78617859 |
| 150 | MP0009765_abnormal_xenobiotic_induced | 0.78567898 |
| 151 | MP0001970_abnormal_pain_threshold | 0.78525027 |
| 152 | MP0005253_abnormal_eye_physiology | 0.78332852 |
| 153 | MP0009046_muscle_twitch | 0.78299147 |
| 154 | MP0003984_embryonic_growth_retardation | 0.78237235 |
| 155 | MP0003935_abnormal_craniofacial_develop | 0.77627904 |
| 156 | MP0000750_abnormal_muscle_regeneration | 0.76765285 |
| 157 | MP0003936_abnormal_reproductive_system | 0.76705213 |
| 158 | MP0005083_abnormal_biliary_tract | 0.75601590 |
| 159 | MP0002133_abnormal_respiratory_system | 0.75386721 |
| 160 | MP0005388_respiratory_system_phenotype | 0.75386721 |
| 161 | MP0001614_abnormal_blood_vessel | 0.75054810 |
| 162 | MP0005508_abnormal_skeleton_morphology | 0.75004632 |
| 163 | MP0005671_abnormal_response_to | 0.74813507 |
| 164 | MP0003252_abnormal_bile_duct | 0.74747037 |
| 165 | MP0005647_abnormal_sex_gland | 0.74689071 |
| 166 | MP0005501_abnormal_skin_physiology | 0.73795454 |
| 167 | MP0010678_abnormal_skin_adnexa | 0.73705436 |
| 168 | MP0005503_abnormal_tendon_morphology | 0.72587309 |
| 169 | MP0004197_abnormal_fetal_growth/weight/ | 0.72401118 |
| 170 | MP0001216_abnormal_epidermal_layer | 0.71175495 |
| 171 | MP0000579_abnormal_nail_morphology | 0.70704396 |
| 172 | MP0005195_abnormal_posterior_eye | 0.70428791 |
| 173 | MP0002084_abnormal_developmental_patter | 0.69897189 |
| 174 | MP0000427_abnormal_hair_cycle | 0.69739775 |
| 175 | MP0003755_abnormal_palate_morphology | 0.69127281 |
| 176 | MP0002115_abnormal_skeleton_extremities | 0.68213040 |
| 177 | MP0005390_skeleton_phenotype | 0.65558268 |
| 178 | MP0002109_abnormal_limb_morphology | 0.64976687 |
| 179 | MP0002135_abnormal_kidney_morphology | 0.64349480 |
| 180 | MP0008875_abnormal_xenobiotic_pharmacok | 0.63455676 |
| 181 | MP0003938_abnormal_ear_development | 0.59608344 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hyperinsulinemic hypoglycemia (HP:0000825) | 5.37057353 |
| 2 | Pendular nystagmus (HP:0012043) | 4.93205696 |
| 3 | Hypoglycemic seizures (HP:0002173) | 4.50170340 |
| 4 | Symptomatic seizures (HP:0011145) | 4.43431867 |
| 5 | Genetic anticipation (HP:0003743) | 4.39376901 |
| 6 | Porencephaly (HP:0002132) | 4.04983068 |
| 7 | Abolished electroretinogram (ERG) (HP:0000550) | 4.00717386 |
| 8 | Conjunctival hamartoma (HP:0100780) | 3.95204032 |
| 9 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.78256673 |
| 10 | Pancreatic cysts (HP:0001737) | 3.77911568 |
| 11 | Pancreatic fibrosis (HP:0100732) | 3.73222081 |
| 12 | Insulin-resistant diabetes mellitus (HP:0000831) | 3.67287625 |
| 13 | Premature rupture of membranes (HP:0001788) | 3.66291129 |
| 14 | Increased CSF protein (HP:0002922) | 3.60605332 |
| 15 | Keratoconus (HP:0000563) | 3.55019161 |
| 16 | Increased corneal curvature (HP:0100692) | 3.55019161 |
| 17 | Methylmalonic acidemia (HP:0002912) | 3.52243013 |
| 18 | True hermaphroditism (HP:0010459) | 3.52213614 |
| 19 | Severe visual impairment (HP:0001141) | 3.47596736 |
| 20 | Confusion (HP:0001289) | 3.45367247 |
| 21 | Septo-optic dysplasia (HP:0100842) | 3.39498610 |
| 22 | Furrowed tongue (HP:0000221) | 3.36281754 |
| 23 | Abnormality of the proximal phalanges of the hand (HP:0009834) | 3.30826680 |
| 24 | Hamartoma of the eye (HP:0010568) | 3.29526175 |
| 25 | Decreased central vision (HP:0007663) | 3.26629725 |
| 26 | Agitation (HP:0000713) | 3.22182063 |
| 27 | Progressive cerebellar ataxia (HP:0002073) | 3.21282397 |
| 28 | Hypoglycemic coma (HP:0001325) | 3.19311306 |
| 29 | Abnormality of the phalanges of the 2nd finger (HP:0009541) | 3.16604070 |
| 30 | Acanthosis nigricans (HP:0000956) | 3.11904758 |
| 31 | Congenital, generalized hypertrichosis (HP:0004540) | 3.11549441 |
| 32 | Abnormality of the middle phalanx of the 5th finger (HP:0004219) | 3.10211151 |
| 33 | Tetany (HP:0001281) | 2.98753162 |
| 34 | Asplenia (HP:0001746) | 2.94215304 |
| 35 | Short hallux (HP:0010109) | 2.89121617 |
| 36 | Abnormality of the nasal septum (HP:0000419) | 2.88606258 |
| 37 | Hypoplastic pelvis (HP:0008839) | 2.87606308 |
| 38 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.87204923 |
| 39 | Congenital sensorineural hearing impairment (HP:0008527) | 2.84062159 |
| 40 | Bone cyst (HP:0012062) | 2.84030197 |
| 41 | Hyperglycemia (HP:0003074) | 2.83794609 |
| 42 | Abnormality of the phalanges of the 5th finger (HP:0004213) | 2.78399731 |
| 43 | Methylmalonic aciduria (HP:0012120) | 2.73150801 |
| 44 | Aplasia/Hypoplasia of the tibia (HP:0005772) | 2.72569072 |
| 45 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.72059565 |
| 46 | Myocardial infarction (HP:0001658) | 2.71977278 |
| 47 | Glucose intolerance (HP:0000833) | 2.71733749 |
| 48 | Aplasia/Hypoplasia of the spleen (HP:0010451) | 2.69816047 |
| 49 | Short tibia (HP:0005736) | 2.67395287 |
| 50 | Hyporeflexia of lower limbs (HP:0002600) | 2.65393293 |
| 51 | Abnormal pancreas size (HP:0012094) | 2.65149829 |
| 52 | 3-Methylglutaconic aciduria (HP:0003535) | 2.62601140 |
| 53 | Abnormality of the middle phalanges of the toes (HP:0010183) | 2.62031854 |
| 54 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 2.60405068 |
| 55 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.60132046 |
| 56 | Chorioretinal atrophy (HP:0000533) | 2.58972430 |
| 57 | Oral leukoplakia (HP:0002745) | 2.58348563 |
| 58 | Hand muscle atrophy (HP:0009130) | 2.56412046 |
| 59 | Aplasia/Hypoplasia of the 1st metacarpal (HP:0010026) | 2.54802040 |
| 60 | Short 1st metacarpal (HP:0010034) | 2.54802040 |
| 61 | Abnormality of the axillary hair (HP:0100134) | 2.50262037 |
| 62 | Abnormality of secondary sexual hair (HP:0009888) | 2.50262037 |
| 63 | Long foot (HP:0001833) | 2.49675824 |
| 64 | Mesomelia (HP:0003027) | 2.48341373 |
| 65 | Homocystinuria (HP:0002156) | 2.46768742 |
| 66 | Abnormality of homocysteine metabolism (HP:0010919) | 2.46768742 |
| 67 | Absent hand (HP:0004050) | 2.45931207 |
| 68 | Spinal rigidity (HP:0003306) | 2.45287760 |
| 69 | Morphological abnormality of the middle ear (HP:0008609) | 2.41462130 |
| 70 | Meningioma (HP:0002858) | 2.38379800 |
| 71 | Small hand (HP:0200055) | 2.36131944 |
| 72 | Aplasia/Hypoplasia of the phalanges of the toes (HP:0010173) | 2.35618466 |
| 73 | Cone-rod dystrophy (HP:0000548) | 2.32824691 |
| 74 | Gaze-evoked nystagmus (HP:0000640) | 2.32688258 |
| 75 | Goiter (HP:0000853) | 2.31617972 |
| 76 | Shallow orbits (HP:0000586) | 2.31242390 |
| 77 | Nephronophthisis (HP:0000090) | 2.31049404 |
| 78 | Short humerus (HP:0005792) | 2.29471656 |
| 79 | Epidermoid cyst (HP:0200040) | 2.29381184 |
| 80 | Pigmentary retinal degeneration (HP:0001146) | 2.29153131 |
| 81 | Wrist flexion contracture (HP:0001239) | 2.28947581 |
| 82 | Short femoral neck (HP:0100864) | 2.28939461 |
| 83 | Submucous cleft hard palate (HP:0000176) | 2.27786851 |
| 84 | Insulin resistance (HP:0000855) | 2.24450156 |
| 85 | Cystic liver disease (HP:0006706) | 2.23763000 |
| 86 | Increased connective tissue (HP:0009025) | 2.23042089 |
| 87 | Attenuation of retinal blood vessels (HP:0007843) | 2.22781489 |
| 88 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 2.22643638 |
| 89 | Annular pancreas (HP:0001734) | 2.21795045 |
| 90 | Gonadotropin excess (HP:0000837) | 2.20501388 |
| 91 | Long nose (HP:0003189) | 2.18488336 |
| 92 | Abnormality of the 1st metacarpal (HP:0010009) | 2.17883837 |
| 93 | Hemiplegia (HP:0002301) | 2.15056041 |
| 94 | Ectopic kidney (HP:0000086) | 2.14181627 |
| 95 | Congenital stationary night blindness (HP:0007642) | 2.12552971 |
| 96 | Upper limb amyotrophy (HP:0009129) | 2.12284070 |
| 97 | Distal upper limb amyotrophy (HP:0007149) | 2.12284070 |
| 98 | Autoimmune thrombocytopenia (HP:0001973) | 2.11363240 |
| 99 | Abnormality of midbrain morphology (HP:0002418) | 2.10997836 |
| 100 | Molar tooth sign on MRI (HP:0002419) | 2.10997836 |
| 101 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 2.08426017 |
| 102 | Absent/shortened dynein arms (HP:0200106) | 2.08426017 |
| 103 | Thyroiditis (HP:0100646) | 2.07510788 |
| 104 | Difficulty running (HP:0009046) | 2.07224019 |
| 105 | Abnormality of the renal collecting system (HP:0004742) | 2.06941716 |
| 106 | Basal ganglia calcification (HP:0002135) | 2.06616498 |
| 107 | Aplasia/Hypoplasia of the tongue (HP:0010295) | 2.05780660 |
| 108 | Aplasia/hypoplasia of the humerus (HP:0006507) | 2.05513237 |
| 109 | Abnormality of methionine metabolism (HP:0010901) | 2.04996436 |
| 110 | Adactyly (HP:0009776) | 2.04858963 |
| 111 | Short 4th metacarpal (HP:0010044) | 2.04857514 |
| 112 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 2.04857514 |
| 113 | Muscle fiber splitting (HP:0003555) | 2.03211499 |
| 114 | Visual hallucinations (HP:0002367) | 2.02153470 |
| 115 | Abnormality of the hepatic vasculature (HP:0006707) | 2.01999949 |
| 116 | Abnormality of DNA repair (HP:0003254) | 2.00446800 |
| 117 | Upper limb muscle weakness (HP:0003484) | 2.00419490 |
| 118 | Aplasia/Hypoplasia involving the pelvis (HP:0009103) | 2.00179268 |
| 119 | Optic nerve hypoplasia (HP:0000609) | 1.99689463 |
| 120 | Male infertility (HP:0003251) | 1.96893579 |
| 121 | Turricephaly (HP:0000262) | 1.96791999 |
| 122 | Hematochezia (HP:0002573) | 1.96431861 |
| 123 | Sclerocornea (HP:0000647) | 1.95618897 |
| 124 | Radial bowing (HP:0002986) | 1.95498081 |
| 125 | Fused cervical vertebrae (HP:0002949) | 1.95385236 |
| 126 | Absent eyebrow (HP:0002223) | 1.95080802 |
| 127 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.94803950 |
| 128 | Hypoplastic labia majora (HP:0000059) | 1.94646973 |
| 129 | Mitral valve prolapse (HP:0001634) | 1.92996999 |
| 130 | Venous insufficiency (HP:0005293) | 1.92969059 |
| 131 | Hyperglycinuria (HP:0003108) | 1.92962484 |
| 132 | Male pseudohermaphroditism (HP:0000037) | 1.92248695 |
| 133 | Cerebral aneurysm (HP:0004944) | 1.91383381 |
| 134 | Tetraparesis (HP:0002273) | 1.91262928 |
| 135 | Abnormal glucose tolerance (HP:0001952) | 1.90749723 |
| 136 | Intellectual disability, profound (HP:0002187) | 1.90596914 |
| 137 | Short phalanx of the thumb (HP:0009660) | 1.89991673 |
| 138 | Aplasia/Hypoplasia involving the femoral head and neck (HP:0009108) | 1.89786248 |
| 139 | Skin nodule (HP:0200036) | 1.89015777 |
| 140 | Venous abnormality (HP:0002624) | 1.88998935 |
| 141 | Stenosis of the external auditory canal (HP:0000402) | 1.88947656 |
| 142 | Natal tooth (HP:0000695) | 1.88612150 |
| 143 | Abnormality of the labia (HP:0000058) | 1.88394058 |
| 144 | Short palpebral fissure (HP:0012745) | 1.88393887 |
| 145 | Protrusio acetabuli (HP:0003179) | 1.88328322 |
| 146 | Aplasia/Hypoplasia of the middle phalanx of the 5th finger (HP:0009161) | 1.88293299 |
| 147 | Focal segmental glomerulosclerosis (HP:0000097) | 1.88131691 |
| 148 | Abnormality of the renal medulla (HP:0100957) | 1.88019365 |
| 149 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.87137939 |
| 150 | Advanced eruption of teeth (HP:0006288) | 1.86877494 |
| 151 | Oligomenorrhea (HP:0000876) | 1.86834032 |
| 152 | Birth length less than 3rd percentile (HP:0003561) | 1.86347983 |
| 153 | Hypoplastic ischia (HP:0003175) | 1.86202329 |
| 154 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 1.86006764 |
| 155 | Anencephaly (HP:0002323) | 1.85798435 |
| 156 | Transitional cell carcinoma of the bladder (HP:0006740) | 1.85077464 |
| 157 | Esophageal varix (HP:0002040) | 1.84701176 |
| 158 | Complete atrioventricular canal defect (HP:0001674) | 1.84681535 |
| 159 | Atrophic scars (HP:0001075) | 1.83327774 |
| 160 | Abnormality of the renal cortex (HP:0011035) | 1.82874760 |
| 161 | Synostosis of carpal bones (HP:0005048) | 1.82096797 |
| 162 | Bronchomalacia (HP:0002780) | 1.80730105 |
| 163 | Prominent nose (HP:0000448) | 1.80304704 |
| 164 | Abnormality of the 2nd finger (HP:0004100) | 1.79988435 |
| 165 | Impaired smooth pursuit (HP:0007772) | 1.79800094 |
| 166 | Persistence of primary teeth (HP:0006335) | 1.78531040 |
| 167 | Abnormality of the labia majora (HP:0012881) | 1.78398265 |
| 168 | Hemiparesis (HP:0001269) | 1.77846178 |
| 169 | Uterine leiomyosarcoma (HP:0002891) | 1.76492436 |
| 170 | Leiomyosarcoma (HP:0100243) | 1.76492436 |
| 171 | Narrow palate (HP:0000189) | 1.76405402 |
| 172 | Abnormality of chromosome stability (HP:0003220) | 1.76347412 |
| 173 | Bladder neoplasm (HP:0009725) | 1.75722894 |
| 174 | Bladder carcinoma (HP:0002862) | 1.75722894 |
| 175 | Hypoalphalipoproteinemia (HP:0003233) | 1.75117678 |
| 176 | Type I diabetes mellitus (HP:0100651) | 1.69670286 |
| 177 | Abnormality of the ischium (HP:0003174) | 1.69303044 |
| 178 | Delayed puberty (HP:0000823) | 1.68940495 |
| 179 | Portal hypertension (HP:0001409) | 1.67244100 |
| 180 | Thick nail (HP:0001805) | 1.67239081 |
| 181 | Abnormality of the intrinsic pathway (HP:0010989) | 1.66038128 |
| 182 | Xanthomatosis (HP:0000991) | 1.65219404 |
| 183 | Hypomagnesemia (HP:0002917) | 1.64928465 |
| 184 | Abnormality of the labia minora (HP:0012880) | 1.64048929 |
| 185 | Bicornuate uterus (HP:0000813) | 1.62757845 |
| 186 | Enlarged penis (HP:0000040) | 1.61587468 |
| 187 | Progressive external ophthalmoplegia (HP:0000590) | 1.58873204 |
| 188 | Abnormality of the aortic arch (HP:0012303) | 1.58646330 |
| 189 | Conjunctival telangiectasia (HP:0000524) | 1.58416599 |
| 190 | Microretrognathia (HP:0000308) | 1.58206841 |
| 191 | Fibular aplasia (HP:0002990) | 1.57063080 |
| 192 | Hemorrhage of the eye (HP:0011885) | 1.55248952 |
| 193 | Peritonitis (HP:0002586) | 1.54850901 |
| 194 | Hypoplasia of the uterus (HP:0000013) | 1.54652266 |
| 195 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.54252935 |
| 196 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.54252935 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ADRBK2 | 4.30722545 |
| 2 | CAMK1D | 4.18036687 |
| 3 | CAMK1G | 3.38015246 |
| 4 | GRK1 | 3.03427779 |
| 5 | BMX | 2.92422309 |
| 6 | ACVR1B | 2.33628501 |
| 7 | TAF1 | 2.29214738 |
| 8 | MST4 | 2.24959815 |
| 9 | INSRR | 2.24156312 |
| 10 | NUAK1 | 2.17258874 |
| 11 | TEC | 2.14071824 |
| 12 | BMPR1B | 2.08578392 |
| 13 | AKT3 | 2.06884627 |
| 14 | MAP4K2 | 2.01549711 |
| 15 | LATS1 | 2.01532219 |
| 16 | TIE1 | 11.7250353 |
| 17 | GRK7 | 1.96122458 |
| 18 | TNIK | 1.91067628 |
| 19 | CDK12 | 1.87384453 |
| 20 | MAP3K12 | 1.78109309 |
| 21 | TAOK3 | 1.61945993 |
| 22 | PDK4 | 1.51237714 |
| 23 | PDK3 | 1.51237714 |
| 24 | ICK | 1.51223088 |
| 25 | STK24 | 1.49863448 |
| 26 | TLK1 | 1.49588939 |
| 27 | PRKD3 | 1.48311199 |
| 28 | FRK | 1.45243797 |
| 29 | ZAK | 1.42961088 |
| 30 | TXK | 1.40799169 |
| 31 | BLK | 1.38408566 |
| 32 | LATS2 | 1.34761494 |
| 33 | VRK2 | 1.32991831 |
| 34 | IKBKB | 1.32862651 |
| 35 | TSSK6 | 1.26658697 |
| 36 | EIF2AK3 | 1.25386761 |
| 37 | TGFBR2 | 1.15261205 |
| 38 | STK16 | 1.10391956 |
| 39 | MUSK | 1.10286513 |
| 40 | SGK2 | 1.09455273 |
| 41 | FLT3 | 1.05679872 |
| 42 | ADRBK1 | 1.05621791 |
| 43 | CSNK1G1 | 1.04062222 |
| 44 | BRSK2 | 1.03852539 |
| 45 | SIK1 | 1.03811796 |
| 46 | PDK2 | 1.03084928 |
| 47 | MTOR | 1.00720782 |
| 48 | VRK1 | 1.00425586 |
| 49 | MYLK | 0.99583753 |
| 50 | SGK3 | 0.94727625 |
| 51 | DYRK1B | 0.92891551 |
| 52 | SGK494 | 0.90946180 |
| 53 | SGK223 | 0.90946180 |
| 54 | CLK1 | 0.89933587 |
| 55 | ABL2 | 0.88681109 |
| 56 | PNCK | 0.88138646 |
| 57 | STK3 | 0.84311991 |
| 58 | ERBB4 | 0.84114391 |
| 59 | MET | 0.82606924 |
| 60 | FGFR2 | 0.82246393 |
| 61 | PLK2 | 0.77775157 |
| 62 | PRKAA2 | 0.75573934 |
| 63 | MAP3K2 | 0.75170303 |
| 64 | CHUK | 0.72286204 |
| 65 | DDR2 | 0.70805717 |
| 66 | DAPK2 | 0.70492457 |
| 67 | EPHA2 | 0.69903222 |
| 68 | EPHA3 | 0.69612949 |
| 69 | CSNK1A1L | 0.66085356 |
| 70 | MKNK2 | 0.64182064 |
| 71 | PRKAA1 | 0.64070982 |
| 72 | WNK3 | 0.64069966 |
| 73 | CSNK1G2 | 0.63607881 |
| 74 | OXSR1 | 0.63358124 |
| 75 | PDGFRA | 0.61964940 |
| 76 | FER | 0.61853139 |
| 77 | CSNK1G3 | 0.60856344 |
| 78 | STK38 | 0.60600336 |
| 79 | ERBB3 | 0.59631573 |
| 80 | MAPKAPK5 | 0.59585580 |
| 81 | PBK | 0.59232640 |
| 82 | CDK6 | 0.59082777 |
| 83 | GRK5 | 0.58973152 |
| 84 | JAK1 | 0.57519577 |
| 85 | NLK | 0.57147044 |
| 86 | PAK3 | 0.56983533 |
| 87 | PDPK1 | 0.56788968 |
| 88 | CSNK1A1 | 0.56268911 |
| 89 | MAP3K9 | 0.56250566 |
| 90 | TTN | 0.55908074 |
| 91 | PRKCE | 0.52592148 |
| 92 | TYRO3 | 0.50240843 |
| 93 | MAPK7 | 0.48207189 |
| 94 | PDGFRB | 0.45995732 |
| 95 | PINK1 | 0.45481124 |
| 96 | GSK3A | 0.44944698 |
| 97 | BRD4 | 0.44569272 |
| 98 | INSR | 0.44529845 |
| 99 | NTRK1 | 0.44302512 |
| 100 | WNK1 | 0.44076473 |
| 101 | TRPM7 | 0.43821645 |
| 102 | PTK2B | 0.43560025 |
| 103 | MELK | 0.42855599 |
| 104 | GRK6 | 0.42754815 |
| 105 | NME1 | 0.42296479 |
| 106 | ERBB2 | 0.41963871 |
| 107 | KSR2 | 0.41829748 |
| 108 | PAK6 | 0.41529714 |
| 109 | MAPK10 | 0.40823044 |
| 110 | PRKD1 | 0.39873446 |
| 111 | TRIB3 | 0.39675807 |
| 112 | FGFR3 | 0.39639683 |
| 113 | MAPKAPK3 | 0.39314893 |
| 114 | MAP2K2 | 0.38889105 |
| 115 | IKBKE | 0.38437352 |
| 116 | RPS6KA5 | 0.37904965 |
| 117 | MAP2K1 | 0.37566475 |
| 118 | PRKD2 | 0.37486740 |
| 119 | PRKACA | 0.37427085 |
| 120 | STK38L | 0.37051734 |
| 121 | WNK4 | 0.35765214 |
| 122 | MAPK4 | 0.35116452 |
| 123 | PKN1 | 0.34813675 |
| 124 | EGFR | 0.34739776 |
| 125 | HIPK2 | 0.34736594 |
| 126 | MST1R | 0.34494974 |
| 127 | PIK3CA | 0.34434872 |
| 128 | CAMK2A | 0.33276426 |
| 129 | SGK1 | 0.33206052 |
| 130 | TTK | 0.33025831 |
| 131 | PRKCH | 0.32671416 |
| 132 | PRKCI | 0.32255502 |
| 133 | CASK | 0.32067556 |
| 134 | DAPK3 | 0.31297719 |
| 135 | PIM1 | 0.31217446 |
| 136 | PRKCA | 0.31030492 |
| 137 | PRKCG | 0.30900778 |
| 138 | ALK | 0.30573452 |
| 139 | MAP3K3 | 0.29884837 |
| 140 | DYRK3 | 0.29638596 |
| 141 | IGF1R | 0.29603323 |
| 142 | MAPK13 | 0.28765487 |
| 143 | EPHB1 | 0.28220894 |
| 144 | CSK | 0.27774866 |
| 145 | NEK2 | 0.27496747 |
| 146 | CSNK1E | 0.27083873 |
| 147 | STK39 | 0.26557560 |
| 148 | MARK2 | 0.26408024 |
| 149 | PLK3 | 0.26003907 |
| 150 | PTK2 | 0.25352588 |
| 151 | DYRK2 | 0.24974554 |
| 152 | MAP3K4 | 0.24928335 |
| 153 | FGFR4 | 0.24009284 |
| 154 | MAPK8 | 0.22937661 |
| 155 | MAPK1 | 0.21366841 |
| 156 | ABL1 | 0.19929992 |
| 157 | PDK1 | 0.19773073 |
| 158 | MAPK9 | 0.19139979 |
| 159 | NEK9 | 0.19002618 |
| 160 | TYK2 | 0.17504980 |
| 161 | CDK9 | 0.17186730 |
| 162 | RET | 0.16338648 |
| 163 | EIF2AK2 | 0.15386548 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 3.69404333 |
| 2 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 3.46738546 |
| 3 | PPAR signaling pathway_Homo sapiens_hsa03320 | 3.01997868 |
| 4 | Sulfur metabolism_Homo sapiens_hsa00920 | 2.50479639 |
| 5 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 2.28952558 |
| 6 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 2.21928455 |
| 7 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 2.15410366 |
| 8 | Phototransduction_Homo sapiens_hsa04744 | 2.14213072 |
| 9 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 2.08597385 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 1.99413635 |
| 11 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.94760989 |
| 12 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.91195488 |
| 13 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 1.89050164 |
| 14 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.85992835 |
| 15 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.85588299 |
| 16 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.81243683 |
| 17 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.81045030 |
| 18 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 1.69649618 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.66698769 |
| 20 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.66381188 |
| 21 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.63556060 |
| 22 | Adherens junction_Homo sapiens_hsa04520 | 1.61535697 |
| 23 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.61474069 |
| 24 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.57610616 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.55699780 |
| 26 | Basal transcription factors_Homo sapiens_hsa03022 | 1.53479062 |
| 27 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.50255401 |
| 28 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.44288610 |
| 29 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.44053829 |
| 30 | Retinol metabolism_Homo sapiens_hsa00830 | 1.43629347 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.41980214 |
| 32 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41811148 |
| 33 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.38125660 |
| 34 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.37763543 |
| 35 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.36717536 |
| 36 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.36390904 |
| 37 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.34119608 |
| 38 | Insulin resistance_Homo sapiens_hsa04931 | 1.32803799 |
| 39 | Nicotine addiction_Homo sapiens_hsa05033 | 1.31504526 |
| 40 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 1.30508568 |
| 41 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.28890130 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.28646674 |
| 43 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.22153040 |
| 44 | RNA polymerase_Homo sapiens_hsa03020 | 1.19687752 |
| 45 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.18115728 |
| 46 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.17819864 |
| 47 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.17707100 |
| 48 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 1.17214347 |
| 49 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.15746983 |
| 50 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.15320737 |
| 51 | Asthma_Homo sapiens_hsa05310 | 1.13604211 |
| 52 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 1.12720858 |
| 53 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 1.10634408 |
| 54 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 1.06552509 |
| 55 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.04480536 |
| 56 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.04230434 |
| 57 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 1.04207276 |
| 58 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.03804354 |
| 59 | Prostate cancer_Homo sapiens_hsa05215 | 1.03010512 |
| 60 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 1.02584396 |
| 61 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.02300502 |
| 62 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02235600 |
| 63 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.01288400 |
| 64 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 1.01044525 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.99992655 |
| 66 | Morphine addiction_Homo sapiens_hsa05032 | 0.98474257 |
| 67 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.97448971 |
| 68 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.96698582 |
| 69 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.95706981 |
| 70 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.93800087 |
| 71 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.93657728 |
| 72 | Parkinsons disease_Homo sapiens_hsa05012 | 0.93153812 |
| 73 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.92739146 |
| 74 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.88079990 |
| 75 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.87145853 |
| 76 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.84317003 |
| 77 | RNA degradation_Homo sapiens_hsa03018 | 0.83616642 |
| 78 | Alzheimers disease_Homo sapiens_hsa05010 | 0.81201295 |
| 79 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.79724673 |
| 80 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.79714764 |
| 81 | Focal adhesion_Homo sapiens_hsa04510 | 0.79250843 |
| 82 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.79078370 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.77755578 |
| 84 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.76353497 |
| 85 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.75190259 |
| 86 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.74597239 |
| 87 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.74395828 |
| 88 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.72875393 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.72610042 |
| 90 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.71611288 |
| 91 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.71017440 |
| 92 | Lysine degradation_Homo sapiens_hsa00310 | 0.70722849 |
| 93 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.69817562 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.69581211 |
| 95 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.68165020 |
| 96 | Insulin secretion_Homo sapiens_hsa04911 | 0.67790385 |
| 97 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.67451617 |
| 98 | Amoebiasis_Homo sapiens_hsa05146 | 0.67433967 |
| 99 | ABC transporters_Homo sapiens_hsa02010 | 0.66177166 |
| 100 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.65672267 |
| 101 | Circadian rhythm_Homo sapiens_hsa04710 | 0.65592130 |
| 102 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.65530161 |
| 103 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.65135062 |
| 104 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.64516380 |
| 105 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.63500725 |
| 106 | Bladder cancer_Homo sapiens_hsa05219 | 0.63419694 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63224170 |
| 108 | Renin secretion_Homo sapiens_hsa04924 | 0.62119740 |
| 109 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.61708958 |
| 110 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.61679008 |
| 111 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.60053195 |
| 112 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.59614489 |
| 113 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.59137072 |
| 114 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.59111859 |
| 115 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.59084081 |
| 116 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.58907209 |
| 117 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.58547334 |
| 118 | Endocytosis_Homo sapiens_hsa04144 | 0.58464208 |
| 119 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.57061098 |
| 120 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.57051618 |
| 121 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.56987010 |
| 122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.56418699 |
| 123 | Tight junction_Homo sapiens_hsa04530 | 0.55979654 |
| 124 | Prion diseases_Homo sapiens_hsa05020 | 0.55913368 |
| 125 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.55558141 |
| 126 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.55488612 |
| 127 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.54523291 |
| 128 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.54405080 |
| 129 | Mineral absorption_Homo sapiens_hsa04978 | 0.53816766 |
| 130 | Endometrial cancer_Homo sapiens_hsa05213 | 0.53751566 |
| 131 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.53677951 |
| 132 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.53207050 |
| 133 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.53077117 |
| 134 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.52417965 |
| 135 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.51653463 |
| 136 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.51329944 |
| 137 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51323494 |
| 138 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.51013288 |
| 139 | Melanoma_Homo sapiens_hsa05218 | 0.50241073 |
| 140 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.49330557 |
| 141 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.49257667 |
| 142 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.49059396 |
| 143 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.49013296 |
| 144 | Huntingtons disease_Homo sapiens_hsa05016 | 0.48662174 |
| 145 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.48600632 |
| 146 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.47783852 |
| 147 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.46573499 |
| 148 | Hepatitis C_Homo sapiens_hsa05160 | 0.46280466 |
| 149 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.46214165 |
| 150 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.45150706 |
| 151 | Olfactory transduction_Homo sapiens_hsa04740 | 0.44801635 |
| 152 | Malaria_Homo sapiens_hsa05144 | 0.44225969 |
| 153 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.44203327 |
| 154 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.43362387 |
| 155 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.42660086 |
| 156 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.41765366 |
| 157 | Glioma_Homo sapiens_hsa05214 | 0.41259120 |
| 158 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.40637844 |
| 159 | Gap junction_Homo sapiens_hsa04540 | 0.40565337 |
| 160 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.40475171 |
| 161 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.39493232 |
| 162 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.39015499 |
| 163 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.38950875 |
| 164 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.38595146 |
| 165 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38493924 |
| 166 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.38385241 |
| 167 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.38267838 |
| 168 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.37908906 |
| 169 | Pathways in cancer_Homo sapiens_hsa05200 | 0.34953084 |

